State of Michigan Retirement System Has $14.67 Million Position in HCA Healthcare, Inc. (NYSE:HCA)

State of Michigan Retirement System lessened its holdings in shares of HCA Healthcare, Inc. (NYSE:HCAFree Report) by 1.8% in the fourth quarter, Holdings Channel.com reports. The fund owned 54,209 shares of the company’s stock after selling 1,000 shares during the quarter. State of Michigan Retirement System’s holdings in HCA Healthcare were worth $14,673,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of the business. Norges Bank bought a new position in shares of HCA Healthcare during the fourth quarter worth $547,104,000. Royal Bank of Canada boosted its position in shares of HCA Healthcare by 102.0% during the second quarter. Royal Bank of Canada now owns 3,650,988 shares of the company’s stock worth $1,108,001,000 after purchasing an additional 1,843,887 shares in the last quarter. Morgan Stanley boosted its position in shares of HCA Healthcare by 51.5% during the fourth quarter. Morgan Stanley now owns 2,229,190 shares of the company’s stock worth $534,917,000 after purchasing an additional 758,127 shares in the last quarter. MFN Partners Management LP lifted its position in HCA Healthcare by 102.9% in the 1st quarter. MFN Partners Management LP now owns 1,261,201 shares of the company’s stock valued at $316,081,000 after acquiring an additional 639,701 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership lifted its position in HCA Healthcare by 14.1% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,800,847 shares of the company’s stock valued at $701,948,000 after acquiring an additional 347,177 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Buying and Selling

In related news, SVP Kathleen M. Whalen sold 4,262 shares of the stock in a transaction on Friday, February 9th. The shares were sold at an average price of $306.21, for a total transaction of $1,305,067.02. Following the transaction, the senior vice president now directly owns 10,250 shares of the company’s stock, valued at $3,138,652.50. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In related news, EVP Michael S. Cuffe sold 3,200 shares of the firm’s stock in a transaction dated Wednesday, January 31st. The shares were sold at an average price of $306.79, for a total transaction of $981,728.00. Following the transaction, the executive vice president now directly owns 24,929 shares of the company’s stock, valued at $7,647,967.91. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Kathleen M. Whalen sold 4,262 shares of the firm’s stock in a transaction dated Friday, February 9th. The shares were sold at an average price of $306.21, for a total transaction of $1,305,067.02. Following the transaction, the senior vice president now directly owns 10,250 shares in the company, valued at $3,138,652.50. The disclosure for this sale can be found here. Insiders have sold a total of 14,840 shares of company stock valued at $4,588,869 over the last ninety days. 1.70% of the stock is owned by corporate insiders.

HCA Healthcare Price Performance

Shares of NYSE:HCA opened at $329.35 on Wednesday. HCA Healthcare, Inc. has a one year low of $215.96 and a one year high of $334.49. The company has a debt-to-equity ratio of 35.07, a current ratio of 1.18 and a quick ratio of 1.02. The firm has a 50 day simple moving average of $313.78 and a 200 day simple moving average of $274.88. The company has a market cap of $87.11 billion, a price-to-earnings ratio of 17.35, a PEG ratio of 1.66 and a beta of 1.65.

HCA Healthcare (NYSE:HCAGet Free Report) last posted its quarterly earnings data on Tuesday, January 30th. The company reported $5.90 earnings per share for the quarter, topping the consensus estimate of $5.05 by $0.85. HCA Healthcare had a net margin of 8.07% and a return on equity of 996.30%. The company had revenue of $17.30 billion during the quarter, compared to analysts’ expectations of $16.51 billion. During the same period in the prior year, the company posted $4.64 earnings per share. HCA Healthcare’s revenue for the quarter was up 11.7% compared to the same quarter last year. Research analysts predict that HCA Healthcare, Inc. will post 20.49 earnings per share for the current fiscal year.

HCA Healthcare declared that its board has authorized a share repurchase plan on Tuesday, January 30th that permits the company to buyback $6.00 billion in outstanding shares. This buyback authorization permits the company to purchase up to 7.4% of its shares through open market purchases. Shares buyback plans are typically a sign that the company’s board of directors believes its shares are undervalued.

HCA Healthcare Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, March 29th. Investors of record on Friday, March 15th were paid a dividend of $0.66 per share. The ex-dividend date was Thursday, March 14th. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.60. This represents a $2.64 annualized dividend and a yield of 0.80%. HCA Healthcare’s dividend payout ratio is currently 13.91%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on HCA shares. StockNews.com cut shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Thursday, February 15th. Sanford C. Bernstein lowered shares of HCA Healthcare from an “outperform” rating to a “market perform” rating and lifted their price target for the company from $277.00 to $301.00 in a research note on Thursday, January 4th. The Goldman Sachs Group lowered shares of HCA Healthcare from a “buy” rating to a “neutral” rating and set a $271.00 price target on the stock. in a research note on Monday, December 11th. Wells Fargo & Company lifted their price target on shares of HCA Healthcare from $303.00 to $315.00 and gave the company an “equal weight” rating in a research note on Thursday, March 28th. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $335.00 price objective on shares of HCA Healthcare in a research note on Tuesday, March 5th. Four analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $311.47.

Check Out Our Latest Report on HCA Healthcare

HCA Healthcare Company Profile

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

See Also

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.